|
SARS-CoV-2 |
SARS-CoV-2 and Asthma |
|
Total patients |
2164 (34,2%) |
131 (22,7%) |
OR 0,56 (CI 0,46:0,59)
p<0,0012
|
Mean Age |
68±17 |
64±17 |
MD 4 (CI -1;-7) p <
0,011
|
Gender (woman) |
912 (42 %) |
79 (60%) |
OR 2,09 (CI 1,46:2,99)
p<0,0012
|
Mortality |
203 (9,3%) |
10 (7,6%) |
OR 0,81 (CI 0,41;1,55)
p=0,502
|
HBP |
1253 (58%) |
73 (56%) |
OR 0,92 (CI 0,64;1,30)
p=0,622
|
Dislypidaemia |
761 (35%) |
49 (37%) |
OR 1,10 (CI 0,76;1,59) p=0,60
2
|
DM |
574 (27%) |
27 (21%) |
OR 0,72 (CI 0,47;1,11)
p=0,132
|
Smoking |
137 (6%) |
9 (7%) |
OR 1,09 (CI 0,54:2,19)
p=0,812
|